230 related articles for article (PubMed ID: 34899718)
1. High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
Aubergeon L; Sawaf M; Felten R; Gottenberg JE; Dumortier H; Monneaux F
Front Immunol; 2021; 12():767099. PubMed ID: 34899718
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
[TBL] [Abstract][Full Text] [Related]
3. Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.
Sawaf M; Fauny JD; Felten R; Sagez F; Gottenberg JE; Dumortier H; Monneaux F
JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997289
[TBL] [Abstract][Full Text] [Related]
4. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
Oster C; Wilde B; Specker C; Sun M; Kribben A; Witzke O; Dolff S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514450
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based regimen promotes inhibitory costimulatory signal of HVEM/BTLA/CD160/LIGHT pathway in allo-renal recipients.
Bai Y; Shi Y; Li Y; Cai B; Zou Y; Wang L
Transpl Immunol; 2013 Jan; 28(1):38-47. PubMed ID: 23165214
[TBL] [Abstract][Full Text] [Related]
6. Distinct Changes of BTLA and HVEM Expressions in Circulating CD4
Liu J; Li J; He M; Zhang GL; Zhao Q
J Immunol Res; 2018; 2018():4561571. PubMed ID: 30116751
[TBL] [Abstract][Full Text] [Related]
7. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
8. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of BTLA and HVEM Expression on Circulating CD4
Song HF; Chen XJ; Tang PJ; Xu P; Huang ZY; Wang XF
Viral Immunol; 2022 May; 35(4):291-302. PubMed ID: 35196150
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
[TBL] [Abstract][Full Text] [Related]
11. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
Gertner-Dardenne J; Fauriat C; Orlanducci F; Thibult ML; Pastor S; Fitzgibbon J; Bouabdallah R; Xerri L; Olive D
Blood; 2013 Aug; 122(6):922-31. PubMed ID: 23692853
[TBL] [Abstract][Full Text] [Related]
12. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
[TBL] [Abstract][Full Text] [Related]
13. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD4+ T cells.
Owada T; Watanabe N; Oki M; Oya Y; Saito Y; Saito T; Iwamoto I; Murphy TL; Murphy KM; Nakajima H
J Leukoc Biol; 2010 Mar; 87(3):425-32. PubMed ID: 19892849
[TBL] [Abstract][Full Text] [Related]
15. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
Valencia X; Yarboro C; Illei G; Lipsky PE
J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
[TBL] [Abstract][Full Text] [Related]
16. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
[TBL] [Abstract][Full Text] [Related]
17. BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3
Zhang JA; Lu YB; Wang WD; Liu GB; Chen C; Shen L; Luo HL; Xu H; Peng Y; Luo H; Huang GX; Wu DD; Zheng BY; Yi LL; Chen ZW; Xu JF
Front Immunol; 2020; 11():518. PubMed ID: 32296431
[TBL] [Abstract][Full Text] [Related]
18. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
[TBL] [Abstract][Full Text] [Related]
19. Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.
Sakoda Y; Park JJ; Zhao Y; Kuramasu A; Geng D; Liu Y; Davila E; Tamada K
Blood; 2011 Feb; 117(8):2506-14. PubMed ID: 21220749
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.
De Trez C; Schneider K; Potter K; Droin N; Fulton J; Norris PS; Ha SW; Fu YX; Murphy T; Murphy KM; Pfeffer K; Benedict CA; Ware CF
J Immunol; 2008 Jan; 180(1):238-48. PubMed ID: 18097025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]